Serum and Glucocorticoid-Inducible Kinase 1 (SGK1) in NSCLC Therapy
Non-small cell lung cancer (NSCLC) remains the most prevalent and one of the deadliest cancers worldwide. Despite recent success, there is still an urgent need for new therapeutic strategies. It is also becoming increasingly evident that combinatorial approaches are more effective than single modali...
Main Authors: | Ilaria Guerriero, Gianni Monaco, Vincenzo Coppola, Arturo Orlacchio |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-11-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/13/11/413 |
Similar Items
-
The Serum-‐ and Glucocorticoid-‐Inducible Kinase SGK1 and SGK3 Regulate hERG Channel Expression via Ubiquitin Ligase Nedd4-‐2 and GTPase Rab11
by: Lamothe, SHAWN
Published: (2013) -
The Emerging Role of SGK1 (Serum- and Glucocorticoid-Regulated Kinase 1) in Major Depressive Disorder: Hypothesis and Mechanisms
by: Vincenzo Dattilo, et al.
Published: (2020-08-01) -
LEFTYA Activates the Epithelial Na+ Channel (ENaC) in Endometrial Cells via Serum and Glucocorticoid Inducible Kinase SGK1
by: Madhuri S. Salker, et al.
Published: (2016-09-01) -
SGK’nın Malı Deniz...
by: Nur Hayat Buran
Published: (2013-12-01) -
Up-Regulation of Kir2.1 (KCNJ2) by the Serum & Glucocorticoid Inducible SGK3
by: Carlos Munoz, et al.
Published: (2014-02-01)